Soleus Capital's reduction below 5% removes a passive holder from the 5%+ ownership list. Monitor for any further selling or a potential conversion to a 13D if the fund's intent changes. The filing follows the company's Q3 earnings report (November 2, 2026) which showed a 7.9% YoY revenue decline.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $62.31entry
- T+1 · 6d ago −0.32%α −1.64% · $62.11
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Soleus Capital Master Fund filed an amended Schedule 13G for Inspire Medical Systems, reporting a 4.2% stake (1,206,828 shares) as of September 30, 2026. This is a decrease from the prior filing (Soleus Capital Master Fund previously reported a 5.0%+ stake in August 2026), indicating the fund reduced its position and fell below the 5% threshold. The filing remains passive (Rule 13d-1(c)), with no activist intent.
Key Financial Metrics
Key Facts
- Soleus Capital Master Fund reported 1,206,828 shares of INSP common stock, representing 4.2% of shares outstanding as of September 30, 2026.
- The percentage is based on 28,966,119 shares outstanding as of October 28, 2026, per the company's Form 10-Q.
- This is a decrease from the prior filing (August 13, 2026) where Soleus held a stake above 5%, indicating the fund reduced its position and fell below the 5% threshold.
- The filing is made under Rule 13d-1(c) (passive investor), with no intent to change or influence control.
Financial Impact
Soleus Capital reduced its INSP stake from above 5% to 4.2%, representing a reduction of at least approximately 230,000 shares (based on the prior 5%+ stake vs. current 1,206,828 shares).
Risk Factors
- Soleus Capital may continue to reduce its position, adding selling pressure.
- The fund's exit below 5% removes a previously supportive institutional holder.
- The reduction comes shortly after Q3 earnings that showed a YoY revenue decline.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001213900-26-117543 |
| Document: 0001213900-26-117543-index.html | 0001213900-26-117543 |
| Document: 0001213900-26-117543.txt | 0001213900-26-117543 |
Track record
16 reports on INSP
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $59.52 Now $59.12 −0.67% settles Nov 17
- Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $60.54 to $61.10 Now $59.12 +2.35% ▼ −0.93% −1.29% vs SPY
- Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $62.31 to $62.11 Now $59.12 −5.12% ▼ −0.32% −1.64% vs SPY
- Nov 9, 20267d ago SC 13G/A Bearish 4/10 Viewing Entry $62.31 to $62.11 Now $59.12 +5.12% ▲ +0.32% +1.64% vs SPY
- Nov 2, 202614d ago 8-K Mixed 6/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $61.90 to $66.61 Now $59.12 −4.49% ▲ +7.61% +5.96% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $68.10 to $67.21 Now $59.12 −13.19% ▼ −1.31% −0.83% vs SPY
- Oct 5, 20266w ago Press Release Neutral 1/10 Entry $68.20 Now $59.12 −13.31% No price data
- Jul 27, 202616w ago 3 Neutral 1/10 Entry $51.97 to $51.07 Now $59.12 +13.76% ▼ −1.73% −0.19% vs SPY
- Jul 24, 202616w ago 8-K Neutral 2/10 Entry $50.93 to $51.97 Now $59.12 +16.08% ▲ +2.04% +1.80% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers